GLP-1 weight loss programs work best when combined with nutritional support, activity guidance, and ongoing medical oversight
This is particularly important because GLP-1 medications work by slowing digestion and reducing appetite
Monitoring and Follow-Up After treatment is started, regular follow-up is important
Overall gastrointestinal adverse event rates Across the STEP trials, 72.9% of participants receiving semaglutide 2.4 mg reported at least one gastrointestinal adverse event, compared to 47.1% on placebo
Jerry: I have no choice because of my family history of people dying young
"Medications like these lead to weight loss, which helps to improve sleep apnea," explains Brian Wojeck, MD, MPH, an endocrinologist at Yale Medicine in New Haven, Connecticut